Chester County News and Community Website
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled promising preclinical and Phase 1 data for ratutrelvir, its investigational oral treatment for COVID-19. Presented at the International Conference for …
Traws Pharma Announces Promising Data for Ratutrelvir as a COVID-19 Treatment Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has unveiled groundbreaking results from the CLEAR study, the first head-to-head randomized controlled trial comparing the UroLift™ System with Rezūm™ Water Vapor Therapy (WVTT) …
Study Highlights UroLift™ System’s Advantages Over Rezūm™ in Treating BPH Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE), a clinical-stage biopharmaceutical company, shared its financial results for 2024 and provided a progress update on its lead programs aimed at advancing cancer …
Aprea Therapeutics Reports 2024 Financial Results and Updates on Clinical Innovations Read More
PHILADELPHIA, PA — iECURE, Inc. recently unveiled encouraging early data from its ongoing OTC-HOPE Phase 1/2 study at the 2025 ACMG Annual Clinical Genetics Meeting. The study, which evaluates the …
iECURE Highlights Promising Results from OTC-HOPE Study at 2025 ACMG Genetics Meeting Read More
WILMINGTON, DE — Biopharmaceutical company Incyte (Nasdaq: INCY) has reported encouraging results from its Phase 3 STOP-HS clinical trials evaluating povorcitinib, an oral JAK1 inhibitor, for moderate to severe hidradenitis suppurativa …
Incyte Announces Positive Phase 3 Results for Hidradenitis Suppurativa Treatment Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has shared its corporate updates and financial results for the fourth quarter and full year of 2024, highlighting significant advancements in its clinical …
Annovis Bio Reports Progress in Clinical Trials and Improved Financial Position Read More
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab) for the treatment of adults with moderately to severely …
FDA Approves TREMFYA® for Crohn’s Disease, Offering New Treatment Options Read More NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) shared encouraging findings on its investigational antiviral drug, tivoxavir marboxil (TXM), during the International Society for Antiviral Research (ICAR 2025) in Las Vegas. …
Traws Pharma Unveils Promising Bird Flu Treatment Data Read More
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has announced the results of a groundbreaking study conducted in Japan, which underscores the technological advantages of its XTRAC® Excimer Laser over …
Study Validates Advantages of STRATA Skin Sciences’ XTRAC Laser Technology Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) has released a free, on-demand webinar titled “Why Should I Consider a Clinical Trial?” to address common questions and misconceptions about …
NCCN Launches Free On-Demand Webinar on Cancer Clinical Trials Read More